James P. Boylan
Director · Zenas BioPharma, Inc.
Individual
- 2026
- Jun 17, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies James P. Boylan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Isaac Barchas - $9.94M in IMNM purchases and sales in the last 12 months
- Leon O. Moulder Jr. - $4.12M in ZBIO purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $3.00M in ZBIO purchases and sales in the last 12 months
- Max Rosett - $2.52M in IMNM purchases and sales in the last 12 months
- Robert Lechleider - $2.34M in IMNM purchases and sales in the last 12 months
- Kinney Horn - $2.30M in IMNM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is James P. Boylan?
James P. Boylan is a corporate insider, tracked as Director of Zenas BioPharma, Inc. (ZBIO). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did James P. Boylan last file a Form 4?
The most recent primary Form 4 on record is dated 17 June 2026, one of 3 filings going back to 2026.
